BIOLINERX LTD's ticker is BLRX and the CUSIP is 09071M205. A total of 28 filers reported holding BIOLINERX LTD in Q1 2022. The put-call ratio across all filers is 1.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,334 | +13.8% | 16,667 | 0.0% | 0.01% | +12.5% |
| Q2 2023 | $26,667 | +79.8% | 16,667 | 0.0% | 0.01% | +60.0% |
| Q1 2023 | $14,834 | +50.8% | 16,667 | 0.0% | 0.01% | +66.7% |
| Q4 2022 | $9,834 | -42.2% | 16,667 | -10.7% | 0.00% | -50.0% |
| Q3 2022 | $17,000 | -29.2% | 18,667 | 0.0% | 0.01% | -25.0% |
| Q2 2022 | $24,000 | -25.0% | 18,667 | 0.0% | 0.01% | -20.0% |
| Q1 2022 | $32,000 | -15.8% | 18,667 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $38,000 | -25.5% | 18,667 | 0.0% | 0.01% | -16.7% |
| Q3 2021 | $51,000 | -1.9% | 18,667 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $52,000 | -35.0% | 18,667 | -34.9% | 0.01% | -40.0% |
| Q1 2021 | $80,000 | +11.1% | 28,667 | 0.0% | 0.02% | +5.3% |
| Q4 2020 | $72,000 | +50.0% | 28,667 | -1.1% | 0.02% | +35.7% |
| Q3 2020 | $48,000 | +60.0% | 29,000 | +62.9% | 0.01% | +40.0% |
| Q2 2020 | $30,000 | +66.7% | 17,799 | +29.0% | 0.01% | +42.9% |
| Q1 2020 | $18,000 | -33.3% | 13,799 | +17.0% | 0.01% | -22.2% |
| Q4 2019 | $27,000 | – | 11,799 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parkman Healthcare Partners LLC | 270,665 | $463,000 | 0.14% |
| ACT CAPITAL MANAGEMENT, LLC | 27,500 | $47,000 | 0.05% |
| Cutter & CO Brokerage, Inc. | 18,667 | $32,000 | 0.01% |
| Opaleye Management Inc. | 16,667 | $29,000 | 0.01% |
| Apollon Wealth Management, LLC | 56,410 | $96,000 | 0.01% |
| Sandy Cove Advisors, LLC | 3,597 | $6,000 | 0.01% |
| Atria Wealth Solutions, Inc. | 104,032 | $178,000 | 0.00% |
| Thomasville National Bank | 10,000 | $17,000 | 0.00% |
| Geneos Wealth Management Inc. | 32,950 | $56,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 9,923 | $17,000 | 0.00% |